Idaho · Private Telepsychiatry
Specialized Psychiatric Care in Idaho
Verigrate Health provides physician-led private psychiatric consultation by telepsychiatry to eligible patients who are physically located in Idaho at the time of care. Consultations are personally conducted by Christian S. Monsalve, M.D., a board-certified psychiatrist licensed to practice medicine in Idaho, with particular focus on complex psychiatric consultation, psychiatric deprescribing, and individualized medication tapering.
Verigrate Health’s principal in-person office is in Dallas, Texas. Care for Idaho patients is provided virtually and remains subject to clinical appropriateness, applicable requirements, practice availability, and the patient’s location at the time of the appointment.
Scope of Consultation
A Careful Review of Diagnosis, Medication, and Clinical Context
Diagnostic clarification when prior diagnoses conflict, symptoms remain unexplained, or medication effects and underlying illness are difficult to distinguish.
Individualized review when antidepressants, benzodiazepines, sleep medicines, gabapentinoids, or other psychiatric medications require careful sequencing and gradual change.
Review of benzodiazepine duration, dependence, prior withdrawal, co-prescribed medicines, current benefit, clinical risk, and readiness for change.
Reassessment of ongoing indication, adverse effects, interactions, cumulative medication burden, and whether simplification could strengthen care.
Psychiatric decision-making considered alongside sleep, metabolic health, physical health, substance use, and other medically relevant factors.
Physician consultation for alcohol-related psychiatric complexity, medication strategy, treatment response, evidence-based options, and level-of-care questions.
Medication Stewardship
Psychiatric Medication Tapering in Idaho
Medication reduction is considered only within a broader psychiatric review. Consultation examines the original indication, present benefit, adverse effects, prior dose changes, withdrawal sensitivity, recurrence risk, concurrent treatment, medical context, and the patient’s goals. When tapering is clinically appropriate, the sequence and pace are individualized; discontinuation is never presumed to be the correct outcome.
Review may include escitalopram (Lexapro), sertraline (Zoloft), fluoxetine (Prozac), venlafaxine (Effexor XR), duloxetine (Cymbalta), bupropion, mirtazapine, and tricyclic antidepressants. Planning considers duration, prior benefit, withdrawal sensitivity, recurrence risk, and whether present symptoms reflect the underlying condition, medication effects, or a prior dose change.
Alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), diazepam (Valium), and related medicines are evaluated in relation to duration, dependence, prior withdrawal, concurrent prescriptions, medical risk, and ongoing benefit. If tapering is appropriate, the pace is individualized rather than imposed by a fixed protocol.
Z-drugs and other sleep medications
Sleep-focused review may include zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), orexin receptor antagonists, sedating antidepressants, and other hypnotics. Recommendations distinguish insomnia itself from medication effects, rebound symptoms, withdrawal, and coexisting psychiatric concerns.
Gabapentinoids and other psychiatric medications
Gabapentin, pregabalin, mood stabilizers, antipsychotics, ADHD treatments, anxiolytics, adjunctive medicines, and other psychiatric medications may also be reviewed. Complex regimens are considered as connected systems rather than isolated prescriptions.
Clinical Judgment Before Change
A simpler regimen is not automatically a safer regimen. Recommendations weigh diagnostic clarity, current benefit, adverse effects, withdrawal sensitivity, medical context, available support, and the risks of both changing and continuing treatment.
How Care Works
Physician-Led Psychiatric Consultation Across Idaho
Every Idaho consultation is personally conducted by Christian S. Monsalve, M.D. Care may include review of diagnosis, treatment history, current medications, prior responses, patient goals, and whether continuing, revising, or gradually tapering treatment is most appropriate. Eligible patients may consult from Boise, Meridian, Eagle, Nampa, Coeur d’Alene, Idaho Falls, Twin Falls, Pocatello, the broader Treasure Valley, and elsewhere in Idaho through secure telepsychiatry. Verigrate Health does not maintain a physical office in Idaho; its principal in-person office is in Dallas, Texas.
Practice Structure
Common Questions
Does Verigrate Health provide psychiatric care in Idaho?
Yes. Verigrate Health provides physician-led telepsychiatry to eligible patients who are physically located in Idaho at the time of care. Christian S. Monsalve, M.D. is a board-certified psychiatrist licensed to practice medicine in Idaho and personally conducts consultations.
Does Verigrate Health have an office in Idaho?
No. Verigrate Health does not maintain a physical office in Idaho. Its principal in-person office is in Dallas, Texas, and care for eligible Idaho patients is provided virtually through telepsychiatry.
Can patients in Boise and other Idaho communities receive care?
Eligible patients in Boise, Meridian, Eagle, Nampa, Coeur d’Alene, Idaho Falls, Twin Falls, Pocatello, and other Idaho communities may receive telepsychiatry when clinically appropriate and subject to practice availability and applicable requirements.
Does Verigrate provide medication tapering and psychiatric deprescribing in Idaho?
Yes, when clinically appropriate. Idaho consultations may address psychiatric deprescribing, antidepressant tapering, benzodiazepine tapering, hyperbolic tapering principles, and other individualized medication changes after careful review. Medication reduction is not assumed to be the goal of every consultation.
Can an Idaho physician refer a patient to Verigrate Health?
Yes. Physicians and other treating clinicians in Idaho may refer appropriate patients for complex psychiatric consultation, medication review, psychiatric deprescribing, or tapering consultation. Dr. Monsalve welcomes clinically relevant collaboration with existing treating professionals.